REGAINE

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Hong Kong, Ireland, Lithuania, Malta, New Zealand, Romania, Singapore, United Kingdom, South Africa

Active ingredients

The drug REGAINE contains one active pharmaceutical ingredient (API):

1 Minoxidil UNII 5965120SH1 - MINOXIDIL

Topical administration of minoxidil stimulates hair growth in men and women with androgenic alopecia. The mechanism of stimulating hair growth from minoxidil is not fully understood, but some actions of minoxidil include increasing hair diameter, stimulating new growth and prolonging the developmental phase, and stimulating hair follicle transition from resting phase (telogen) in the growth phase (regenerative). Read about Minoxidil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
REGAINE FOAM Cutaneous foam	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D11AX01	Minoxidil	D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AX Other dermatologicals
Discover more medicines within D11AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1022353, 1022364, 1787676, 1820124
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 76483
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 185507, 185508, 320666, 358555, 95241, 95254, 95255
Country: HK	Department of Health Drug Office	Identifier(s): 52159, 52160, 52161, 64008, 65139
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1008746, 1008747
Country: MT	Medicines Authority	Identifier(s): AA908/13603, MA1315/00601, MA1377/00101, PI908/13601A
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 14343, 17485, 2619
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65436001, W65436002, W67162001, W67162002
Country: SG	Health Sciences Authority	Identifier(s): 04399P, 08213P
Country: ZA	Health Products Regulatory Authority	Identifier(s): U/13.4.2/140, Y/13.4.2/31